Vamikibart is the first targeted, non-steroid treatment designed to address the underlying inflammation driving UME
Liraglutide Injection, 18 mg/3 mL (6 mg/mL) Single-Patient-Use Prefilled Pen is bioequivalent to Victoza Injection, 18 mg/3 mL (6 mg/mL) of Novo Nordisk
Wegovy achieved significant weight loss with one in three study participants losing 20% or more body weight
Isotretinoin capsules are indicated to treat severe, disfiguring nodular acne
700 new scientific and high-skilled jobs to be created in Greater Toronto Area, investing to execute more than 210 AstraZeneca global clinical studies
Quinidine Sulphate helps manage rare irregular heartbeat conditions
She reiterated the nation's commitment to eliminating TB as a public health problem by 2030 and ensuring a healthier future for all
Philips also concluded an agreement with insurers to pay Philips EUR 540 million to cover Respironics recall-related product liability claims
New leadership team announced at NATHEALTH Annual General Meeting 2024
Beneficiaries can create Ayushman Card from their mobile phone using Ayushman App which has been downloaded 52 lakh times since its launch on 13th September, 2023
Subscribe To Our Newsletter & Stay Updated
